Major Force in the Biosimilar Hormones Market 2025: Rising Demand For Hormone Biosimilars Fueled By Prevalence Of Hormonal Deficiencies

How Will the Biosimilar Hormones Market Grow, and What Is the Projected Market Size?
In recent times, the biosimilar hormones market has experienced rapid expansion. The market value is projected to increase from $3.9 billion in 2024 to $4.98 billion in 2025, indicating a compound annual growth rate (CAGR) of 27.5%. Factors such as the escalating incidence of chronic illnesses, rise in elderly population, increased understanding of biosimilar hormones, and improved healthcare accessibility contribute to the growth observed in the historic period.

In the coming years, the biosimilar hormones market size is anticipated to witness significant expansion. The growth rate is projected to touch $11.77 billion in 2029, with a compound annual growth rate (CAGR) of 24.0%. This surge during the predicted period can be linked to proliferating hormone targets, increasing acceptance among patients, advancements in production methods, governmental backing, an influx of clinical trial data, and broader healthcare accessibility. Notable trends that will shape the market during the forecasted period include tailored hormone replacement, launch of new products, issues relating to pricing and access, and a more patient-focused healthcare approach.

What Key Elements Are Boosting Growth in the Biosimilar Hormones Market?
The hormone biosimilar market's growth is influenced by the increasing incidences of deficiencies in growth hormones and metabolic hormones. Over time, the treatments for hormone-associated health conditions have advanced. This enhancement, coupled with the frequent detection of hormonal deficiencies, is leading to higher hormone biosimilar market demand. As per the British Medical Journal, a peer-reviewed medical trade journal from the UK, it's estimated that the incidence of GH deficiency in children globally falls between 1 in 3500 and 1 in 10000, as reported in January 2022. Moreover, a Medscape report stated in June 2022 that around 6,000 adults in the USA are anticipated to be diagnosed with a deficiency in growth hormones. Such a surge in the number of patients with hormonal deficiencies needing treatment fuels the expansion of the biosimilar hormones market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3432&type=smp

Who Are the Major Industry Players Fueling Biosimilar Hormones Market Expansion?
Major companies operating in the biosimilar hormones market include Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., Intas Pharmaceuticals Ltd., Biocon Limited, Mylan, Sanofi, Sandoz Group AG, LG Life Sciences, Ferring Pharmaceuticals, GC Pharma, Pfizer Inc., Dr. Reddy's Laboratories, Amgen Inc., Eli Lilly and Company, Celltrion Inc., Samsungbioepis Co.Ltd, Merck & Co., Biogen Inc., Boehringer Ingelheim, Alvotech, BioXpress Therapeutics, Cipla Limited, Lupin Ltd., Stada Arzneimittel AG, Torrent Pharmaceuticals, Zydus Cadila, Accord Healthcare, Hetero Drugs, Wockhardt

Which Key Developments Are Influencing the Biosimilar Hormones Market?
Prominent players in the biosimilar hormones market are adopting various strategic endeavors such as launching fresh products in previously unexplored areas to reach a wider population. These businesses are emphasizing the distribution of their products across numerous locations to enhance sales and optimize revenue. For example, Alvotech Holdings S.A., a biopharmaceutical firm headquartered in Luxembourg that focuses on the creation of biosimilar drugs, revealed collaborations with Fuji Pharma Co. Ltd., a Japanese pharmaceutical company, for the development of biosimilar drug potentials in Japan in February 2022. Through this alliance, both firms plan to incorporate new aspects in their strategic mix to generate and promote biosimilar medicines in Japan.

How Is the Segmentation of the Biosimilar Hormones Market Defined?
The biosimilar hormones market covered in this report is segmented -

1) By Type: Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types
2) By Application: Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/pharmacy, Specialty Clinics

Subsegments:
1) By Teriparatide Biosimilars: Osteoporosis Treatment, Bone Health Maintenance
2) By Follitropin Alfa Biosimilars: Infertility Treatment, Assisted Reproductive Technology (ART)
3) By Insulin Biosimilars: Type 1 Diabetes Management, Type 2 Diabetes Management
4) By Somatropin Biosimilars: Growth Hormone Deficiency Treatment, Pediatric Growth Disorders
5) By Other Types: Thyroid Hormones, Corticosteroids

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

What Is the Leading Region in the Biosimilar Hormones Market?
The countries covered in the biosimilar hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Is Covered In The Biosimilar Hormones Global Market Report?

- Market Size Analysis: Analyze the Biosimilar Hormones Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Biosimilar Hormones Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Biosimilar Hormones Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Biosimilar Hormones Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3432

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.